Peptide record

TPDB10889

Antibacterial Anticancer Antifungal Antiparasitic Toxicity standard
27 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10889
Antibacterial Anticancer Antifungal Antiparasitic Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia CancerPPD 2.0 dbACP Antifungipept CAFPdb ToxinPred 3.0
standard
No
A 27-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GIGGALLSAGKSALKGLAKGLAEHFAN
Physicochemical Analysis
C114H191N33O33
RDCQMPTWYV
AG
2551.97
10.32
4
1
13
+2
1.43
0.415
108.89
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
3
Residue Composition
number
6
A
0
R
1
N
0
D
0
C
1
E
0
Q
6
G
1
H
1
I
5
L
3
K
0
M
1
F
0
P
2
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 6 R: 0 N: 1 D: 0 C: 0 E: 1 Q: 0 G: 6 H: 1 I: 1 L: 5 K: 3 M: 0 F: 1 P: 0 S: 2 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
27
C114H191N33O33
2551.97
10.32
+2
1.43
0.415
Evidence Records 15 records
Evidence 1 Activity

Activity

MIC
Antibacterial
6.3 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against E. coli (MIC6.3 uM), S. aureus (MIC6.3 uM) and C. albicans (MIC12.5uM) (MIC data provided by Chunfeng Wang).
Evidence 2 Activity

Activity

MIC
Antibacterial
6.3 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

Active against E. coli (MIC6.3 uM), S. aureus (MIC6.3 uM) and C. albicans (MIC12.5uM) (MIC data provided by Chunfeng Wang). Also active against M.
Evidence 3 Activity

Activity

MIC
Antibacterial
12.5 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

Active against E. coli (MIC6.3 uM), S. aureus (MIC6.3 uM) and C. albicans (MIC12.5uM) (MIC data provided by Chunfeng Wang). Also active against M. luteus, and S. cerevisae Ke
Evidence 4 Activity

Activity

IC50
Antibacterial
0.99 µM

Target

human hepatic adenocarcinoma SK-HEP-1 cells

Source & Reference

dbAMP DRAMP

Other

ve against M. luteus, and S. cerevisae Ke T et al., 2012 . ALso has anticancer effects on human hepatic adenocarcinoma SK-HEP-1 cells (IC50 0.99 uM), Hep G2 cells (IC50 2.8 uM) and Huh7 cells (IC50 3.8 uM) after 48 h treatment, also human
Evidence 5 Activity

Activity

MIC
Antifungal
6.3 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against E. coli (MIC6.3 uM), S. aureus (MIC6.3 uM) and C. albicans (MIC12.5uM) (MIC data provided by Chunfeng Wang).
Evidence 6 Activity

Activity

MIC
Antifungal
6.3 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E. coli (MIC6.3 uM), S. aureus (MIC6.3 uM) and C. albicans (MIC12.5uM) (MIC data provided by Chunfeng Wang). Also active against M.
Evidence 7 Activity

Activity

MIC
Antifungal
12.5 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E. coli (MIC6.3 uM), S. aureus (MIC6.3 uM) and C. albicans (MIC12.5uM) (MIC data provided by Chunfeng Wang). Also active against M. luteus, and S. cerevisae Ke
Evidence 8 Activity

Activity

IC50
Antifungal
0.99 µM

Target

human hepatic adenocarcinoma SK-HEP-1 cells

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ve against M. luteus, and S. cerevisae Ke T et al., 2012 . ALso has anticancer effects on human hepatic adenocarcinoma SK-HEP-1 cells (IC50 0.99 uM), Hep G2 cells (IC50 2.8 uM) and Huh7 cells (IC50 3.8 uM) after 48 h treatment, also human
Evidence 9 Activity

Activity

MIC
Antiparasitic
6.3 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against E. coli (MIC6.3 uM), S. aureus (MIC6.3 uM) and C. albicans (MIC12.5uM) (MIC data provided by Chunfeng Wang).
Evidence 10 Activity

Activity

MIC
Antiparasitic
6.3 µM

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

Active against E. coli (MIC6.3 uM), S. aureus (MIC6.3 uM) and C. albicans (MIC12.5uM) (MIC data provided by Chunfeng Wang). Also active against M.
Evidence 11 Activity

Activity

MIC
Antiparasitic
12.5 µM

Target

Candida albicans

Source & Reference

DRAMP

Other

Active against E. coli (MIC6.3 uM), S. aureus (MIC6.3 uM) and C. albicans (MIC12.5uM) (MIC data provided by Chunfeng Wang). Also active against M. luteus, and S. cerevisae Ke
Evidence 12 Activity

Activity

IC50
Antiparasitic
0.99 µM

Target

human hepatic adenocarcinoma SK-HEP-1 cells

Source & Reference

DRAMP

Other

ve against M. luteus, and S. cerevisae Ke T et al., 2012 . ALso has anticancer effects on human hepatic adenocarcinoma SK-HEP-1 cells (IC50 0.99 uM), Hep G2 cells (IC50 2.8 uM) and Huh7 cells (IC50 3.8 uM) after 48 h treatment, also human
Evidence 13 Activity

Activity

2% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
2% Hemolysis | 128 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Discovery of two Bombinin peptides with antimicrobial and anticancer activities from the skin secretion of Oriental Fire-bellied toad, Bombina orientalis | Chem Biol Drug Des | 2017
Evidence 14 Activity

Activity

83% Hemolysis
Toxicity
256 µg/mL
Hemolytic Cytotoxic
83% Hemolysis | 256 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Discovery of two Bombinin peptides with antimicrobial and anticancer activities from the skin secretion of Oriental Fire-bellied toad, Bombina orientalis | Chem Biol Drug Des | 2017
Evidence 15 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref:11835991]Little hemolytic activity at 50 µg/ml against red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Eur J Immunol. 2005 Apr 35(4):1220-1229.##Peptides. 2002 Mar 23(3):427-435.